Abstract
Aims/hypothesis: We aimed to examine the association of type 1 diabetes with school wellbeing among Danish children. Methods: This is a population-based cohort study involving 436,439 Danish children, of which 1499 had a confirmed diagnosis of type 1 diabetes. The children were enrolled in grade levels 4 to 9 (middle school) in Danish public schools in the years 2014–2017. Questionnaire outcomes from the yearly National Wellbeing Survey related to self-efficacy, perceived competences, peer and teacher support, bullying and somatic symptoms were analysed. Ordered logistic regression was used to compare outcomes of children with and without type 1 diabetes, and to compare subgroups of children with type 1 diabetes by different levels of HbA1c and diabetes duration. Primary outcomes were answers to seven pre-specified questionnaire items (scale, 1 to 5). Results: A total of 817,679 questionnaires were initiated, of which n = 2681 were from children with type 1 diabetes. Compared with the background population, children with type 1 diabetes expressed more peer support; adjusted OR 1.17 (95% CI 1.08, 1.27). Children with diabetes also reported more often having a headache; adjusted OR 1.09 (95% CI 1.00, 1.19). Overall, children with poor glycaemic control (HbA1c >70 mmol/mol) had worse outcomes on the wellbeing measures compared with the background population. Even after adjusting for socioeconomic status, they still reported significantly worse perceived competences, less teacher support and more somatic symptoms (stomach ache and headache). Conclusions/interpretation: In Denmark, children with type 1 diabetes generally feel well supported in school but have more headaches than other children. Poor glycaemic control is associated with worse psychological school-related wellbeing. [Figure not available: see fulltext.].
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Diabetologia |
| Vol/bind | 63 |
| Udgave nummer | 11 |
| Sider (fra-til) | 2339-2348 |
| Antal sider | 10 |
| ISSN | 0012-186X |
| DOI | |
| Status | Udgivet - 2020 |
Finansiering
Some of the data were presented as an abstract at the 45th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in 2019, Boston, USA. JS serves as an adviser to Medtronic, Janssen and Novo Nordisk. She owns shares in Novo Nordisk, and has received fees for speaking on behalf of Medtronic, Sanofi, Novo Nordisk and Bayer AG. TME, NS, AG and PRT declare that there are no relationships or activities that might bias, or be perceived to bias, their work. This study has been funded by the Independent Research Fund, Denmark, grant number 8019-00055B. Acknowledgements Authors’ relationships and activities
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS